Search Results 601-610 of 13409 for Birth Control Palette

  1. Obstetrics and Gynecology - Clinical trials

    Immediate Goal: The investigators propose a multicenter pre-birth observational cohort study to develop a Fetal Heart Rate (FHR)/Gestational Age (GA) algorithm ...

  2. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    But the most significant consequence is the missed opportunity for primary prevention of life threatening ventricular arrhythmias after birth because the infant ...

  3. Romidepsin in Treating Patients with Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors with Liver Dysfunction - Mayo Clinic

    Women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study ...

  4. A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant - Mayo Clinic

    Participation eligibility · Agree to practice effective barrier contraception during the entire study treatment period and through 90 days after the last dose of ...

  5. OB Nest: A new vision for prenatal care - Mayo Clinic

    Dr. Butler Tobah and colleagues have researched this prenatal care model, with a randomized, controlled study comparing OB Nest care to standard care. Study ...

  6. Treatment

    Healthcare professionals might suggest chemotherapy to prevent the leiomyosarcoma from returning after surgery. It also might be used to control cancer that ...

  7. Open-Label Extension Study of Setmelanotide - Mayo Clinic

    * Agree to use a highly effective form of contraception and follow the study contraception requirements throughout study duration and for 90 days after.

  8. CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin - Mayo Clinic

    Acceptable methods of contraception include intrauterine device (IUD), oral contraceptive, subdermal implant, double barrier and/or complete abstinence (non- ...

  9. Accelerated vs Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours - Mayo Clinic

    Sexually active patients of reproductive potential are not eligible unless they have agreed to use an effective contraceptive method for the duration of their ...

  10. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    This will be followed by a double-blind, randomized controlled Phase II, to ... 2.2, and agrees to use one of the contraception methods as described in ...